Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation.

Journal: European journal of nuclear medicine and molecular imaging
PMID:

Abstract

Artificial intelligence (AI) will change the face of nuclear medicine and molecular imaging as it will in everyday life. In this review, we focus on the potential applications of AI in the field, both from a physical (radiomics, underlying statistics, image reconstruction and data analysis) and a clinical (neurology, cardiology, oncology) perspective. Challenges for transferability from research to clinical practice are being discussed as is the concept of explainable AI. Finally, we focus on the fields where challenges should be set out to introduce AI in the field of nuclear medicine and molecular imaging in a reliable manner.

Authors

  • Dimitris Visvikis
    LaTIM, INSERM, UMR 1101, Brest 29609, France.
  • Philippe Lambin
    Department of Radiation Oncology (MAASTRO Clinic), Dr. Tanslaan 12, Maastricht, The Netherlands.
  • Kim Beuschau Mauridsen
    Center of Functionally Integrative Neuroscience and MindLab, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Roland Hustinx
    Nuclear Medicine Department, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • Michael Lassmann
    Klinik Und Poliklinik Für Nuklearmedizin, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Christoph Rischpler
  • Kuangyu Shi
    Universitätsklinik für Nuklearmedizin, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland.
  • Jan Pruim
    Medical Imaging Center, Dept. of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.pruim@umcg.nl.